Literature DB >> 7159551

Rat liver thioredoxin and thioredoxin reductase: purification and characterization.

M Luthman, A Holmgren.   

Abstract

A reproducible scheme has been developed for the preparation of rat liver thioredoxin and thioredoxin reductase (EC 1.6.4.5) by using assays based on reduction of insulin and 5,5'-dithiobis(2-nitrobenzoic acid), respectively. Both proteins were purified to homogeneity, as judged from polyacrylamide gel electrophoresis. Thioredoxin had a molecular weight of 12 000 and contained about 110 amino acids including 4 half-cystines and an NH2-terminal valine. Peptide maps of reduced and carboxymethylated thioredoxin showed that the protein had the active center sequence -Cys-Gly-Pro-Cys-Lys-Met- characteristic of thioredoxins also from procaryotes. Prolonged air oxidation of fully reduced thioredoxin created inactive, aggregated disulfide-containing molecules. Thioredoxin reductase showed a subunit molecular weight of 58 000 and a native molecular weight of 116 000. The enzyme was highly specific for NADPH with a Km of 6 microM. It contained FAD as prosthetic group and was sensitive to inhibition by arsenite. Thioredoxin reductase had a Km of 2.5 microM for rat and calf liver thioredoxin and a Kcat of 3000 min-1.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7159551     DOI: 10.1021/bi00269a003

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  122 in total

1.  Mammalian thioredoxin reductase: oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity.

Authors:  S R Lee; S Bar-Noy; J Kwon; R L Levine; T C Stadtman; S G Rhee
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

Review 2.  Thioredoxin reductase.

Authors:  D Mustacich; G Powis
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

3.  Properties of the endogenous components of the thioredoxin system in the psychrophilic eubacterium Pseudoalteromonas haloplanktis TAC 125.

Authors:  Patrizia Falasca; Giovanna Evangelista; Roberta Cotugno; Salvatore Marco; Mariorosario Masullo; Emmanuele De Vendittis; Gennaro Raimo
Journal:  Extremophiles       Date:  2012-04-22       Impact factor: 2.395

4.  Development and hormonal control of thioredoxin and the thioredoxin-reductase system in the rat liver during the perinatal period.

Authors:  J Demarquoy; A Fairand; R Vaillant; C Gautier
Journal:  Experientia       Date:  1991-05-15

5.  Selective targeting of selenocysteine in thioredoxin reductase by the half mustard 2-chloroethyl ethyl sulfide in lung epithelial cells.

Authors:  Yi-Hua Jan; Diane E Heck; Joshua P Gray; Haiyan Zheng; Robert P Casillas; Debra L Laskin; Jeffrey D Laskin
Journal:  Chem Res Toxicol       Date:  2010-06-21       Impact factor: 3.739

6.  Molecular mechanisms of thioredoxin and glutaredoxin as hydrogen donors for Mammalian s phase ribonucleotide reductase.

Authors:  Farnaz Zahedi Avval; Arne Holmgren
Journal:  J Biol Chem       Date:  2009-01-28       Impact factor: 5.157

7.  Growth hormone alters the glutathione S-transferase and mitochondrial thioredoxin systems in long-living Ames dwarf mice.

Authors:  Lalida Rojanathammanee; Sharlene Rakoczy; Holly M Brown-Borg
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-11-27       Impact factor: 6.053

8.  A cellular and molecular investigation of the action of PMX464, a putative thioredoxin inhibitor, in normal and colorectal cancer cell lines.

Authors:  A Mukherjee; K Huber; H Evans; N Lakhani; S Martin
Journal:  Br J Pharmacol       Date:  2007-06-18       Impact factor: 8.739

9.  Metabolic adaptation of short-living growth hormone transgenic mice to methionine restriction and supplementation.

Authors:  Holly M Brown-Borg; Sharlene Rakoczy; Joseph A Wonderlich; Kurt E Borg; Lalida Rojanathammanee
Journal:  Ann N Y Acad Sci       Date:  2018-04       Impact factor: 5.691

10.  Identification and functional characterization of thioredoxin of Mycobacterium tuberculosis.

Authors:  B Wieles; S Nagai; H G Wiker; M Harboe; T H Ottenhoff
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.